Akhtar S - Search Results

1

In vivo studies with antisense oligonucleotides.

Akhtar S, Agrawal S. Akhtar S, et al. Trends Pharmacol Sci. 1997 Jan;18(1):12-8. doi: 10.1016/s0165-6147(96)01002-4. Trends Pharmacol Sci. 1997. PMID: 9114724 Review. No abstract available.

2

Advances in antisense efficacy and delivery.

Agrawal S, Akhtar S. Agrawal S, et al. Among authors: akhtar s. Trends Biotechnol. 1995 Jun;13(6):197-9. doi: 10.1016/S0167-7799(00)88945-3. Trends Biotechnol. 1995. PMID: 7598842 No abstract available.

3

Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?

Akhtar S, Rossi JJ. Akhtar S, et al. J Antimicrob Chemother. 1996 Aug;38(2):159-65. doi: 10.1093/jac/38.2.159. J Antimicrob Chemother. 1996. PMID: 8877530 Review. No abstract available.

4

The delivery of antisense therapeutics.

Akhtar S, Hughes MD, Khan A, Bibby M, Hussain M, Nawaz Q, Double J, Sayyed P. Akhtar S, et al. Adv Drug Deliv Rev. 2000 Oct 31;44(1):3-21. doi: 10.1016/s0169-409x(00)00080-6. Adv Drug Deliv Rev. 2000. PMID: 11035194 Review.

5

Cellular uptake and intracellular fate of antisense oligonucleotides.

Akhtar S, Juliano RL. Akhtar S, et al. Trends Cell Biol. 1992 May;2(5):139-44. doi: 10.1016/0962-8924(92)90100-2. Trends Cell Biol. 1992. PMID: 14731968

6

Improved cellular delivery of antisense oligonucleotides using transferrin receptor antibody-oligonucleotide conjugates.

Walker I, Irwin WJ, Akhtar S. Walker I, et al. Among authors: akhtar s. Pharm Res. 1995 Oct;12(10):1548-53. doi: 10.1023/a:1016260110049. Pharm Res. 1995. PMID: 8584498 No abstract available.

7

Direct inhibitory effects of an antisense oligodeoxynucleotide upon the volume-sensitive chloride current in rat osteoblast-like (ROS 17/2.8) cells.

Gosling M, Akhtar S, Smith JW, Poyner DR. Gosling M, et al. Among authors: akhtar s. Biochem Biophys Res Commun. 1996 Oct 3;227(1):15-9. doi: 10.1006/bbrc.1996.1460. Biochem Biophys Res Commun. 1996. PMID: 8858096

8

Studies on uptake, sub-cellular trafficking and efflux of antisense oligodeoxynucleotides in glioma cells using self-assembling cationic lipoplexes as delivery systems.

Islam A, Handley SL, Thompson KS, Akhtar S. Islam A, et al. Among authors: akhtar s. J Drug Target. 2000;7(5):373-82. doi: 10.3109/10611869909085520. J Drug Target. 2000. PMID: 10721799

9

Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial Caco-2 cells.

Beck GF, Irwin WJ, Nicklin PL, Akhtar S. Beck GF, et al. Among authors: akhtar s. Pharm Res. 1996 Jul;13(7):1028-37. doi: 10.1023/a:1016002606705. Pharm Res. 1996. PMID: 8842040

10

Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.

Khan A, Sommer W, Fuxe K, Akhtar S. Khan A, et al. Among authors: akhtar s. J Drug Target. 2000;8(5):319-34. doi: 10.3109/10611860008997909. J Drug Target. 2000. PMID: 11328659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,740 results

Search Page